Beijing Bohui Innovation Biotechnology Group (300318.SZ) released the third quarter report of 2024, with the company's revenue in the first three quarters reaching 6...
Zhixun Finance APP reports that Beijing Bohui Innovation Biotechnology Group (300318.SZ) released the third quarter report of 2024, with the company's revenue in the first three quarters decreasing by 19.85% to 0.646 billion yuan. The net income attributable to the shareholders of the listed company increased by 67.77% to 23.7177 million yuan year-on-year. The net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses increased by 29.24% to 15.6564 million yuan year-on-year. The basic earnings per share is 0.029 yuan.